Albert Yehaskel is an experienced and accomplished pharmaceutical professional with a distinguished record of achievement and success in the management of regulatory affairs. He has been in the pharmaceutical industry for over 40 years. He has an MSc in Organic Chemistry and an MBA in Economics and Finance. Albert began his career in medicinal research, working for Schering-Plough Corporation, in the area of trisaccharide antibiotic research: Gentamicin, Sisomicin and semi-synthetic antibiotics, replacing a natural sugar with a synthetic moiety to create new synthetic antibiotics. He subsequently gained additional research experience with CNS drugs and polypeptides.